Skip to main content

HUSSMAN STRATEGIC ADVISORS, INC.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1179475 ELLICOTT CITY, MD

Position in REGN

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$3,273,585
+$1,941,702 QoQ
Shares Held
5,250
+150.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#436
of 1,297 holders
Holding Since
Mar 2020
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HUSSMAN STRATEGIC ADVISORS, INC. holds $50,152,977 across 23 Biotechnology names. REGN ranks #4 (6.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 REGN
Regeneron Pharmaceuticals, Inc.
This page
5,250 $3,273,585

All Filings in REGN

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,273,585 5,250
2025-03-31 $1,331,883 2,100
2024-12-31 $1,495,893 2,100
2024-03-31 $2,021,229 2,100
2023-12-31 $3,688,818 4,200
2023-09-30 $3,456,432 4,200
2023-06-30 $5,604,612 7,800
2023-03-31 $6,409,026 7,800
2022-12-31 $5,627,622 7,800
2022-09-30 $6,406,491 9,300
2022-06-30 $6,118,195 10,350
2022-03-31 $4,358,140 6,240
2021-12-31 $3,283,904 5,200
2020-06-30 $2,556,965 4,100
2020-03-31 $2,001,989 4,100